BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 14659409)

  • 1. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.
    Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering.
    Maselli RA; Dunne V; Pascual-Pascual SI; Bowe C; Agius M; Frank R; Wollmann RL
    Muscle Nerve; 2003 Sep; 28(3):293-301. PubMed ID: 12929188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
    Banwell BL; Ohno K; Sieb JP; Engel AG
    Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.
    Ohno K; Engel AG; Shen XM; Selcen D; Brengman J; Harper CM; Tsujino A; Milone M
    Am J Hum Genet; 2002 Apr; 70(4):875-85. PubMed ID: 11791205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
    Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
    Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.
    Cossins J; Burke G; Maxwell S; Spearman H; Man S; Kuks J; Vincent A; Palace J; Fuhrer C; Beeson D
    Brain; 2006 Oct; 129(Pt 10):2773-83. PubMed ID: 16945936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.
    Milone M; Shen XM; Selcen D; Ohno K; Brengman J; Iannaccone ST; Harper CM; Engel AG
    Neurology; 2009 Jul; 73(3):228-35. PubMed ID: 19620612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of previously unreported mutations in CHRNA1, CHRNE and RAPSN genes in three unrelated Italian patients with congenital myasthenic syndromes.
    Brugnoni R; Maggi L; Canioni E; Moroni I; Pantaleoni C; D'Arrigo S; Riva D; Cornelio F; Bernasconi P; Mantegazza R
    J Neurol; 2010 Jul; 257(7):1119-23. PubMed ID: 20157724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
    Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
    Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.
    Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D
    Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction.
    Engel AG; Ohno K; Shen XM; Sine SM
    Ann N Y Acad Sci; 2003 Sep; 998():138-60. PubMed ID: 14592871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common founder effect of rapsyn N88K studied using intragenic markers.
    Dunne V; Maselli RA
    J Hum Genet; 2004; 49(7):366-369. PubMed ID: 15252722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital myasthenic syndromes and the formation of the neuromuscular junction.
    Beeson D; Webster R; Cossins J; Lashley D; Spearman H; Maxwell S; Slater CR; Newsom-Davis J; Palace J; Vincent A
    Ann N Y Acad Sci; 2008; 1132():99-103. PubMed ID: 18567858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital myasthenic syndromes due to mutations in the rapsyn gene].
    Eymard B; Ioos C; Barois A; Estournet B; Mayer M; Fournier E; Yasaki E; Prioleau C; Bauché S; Gaudon K; Leroy JP; Koenig J; Richard P; Hantaï D
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S78-84. PubMed ID: 15269664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of pathogenic mutations in the human rapsyn gene.
    Dunne V; Maselli RA
    J Hum Genet; 2003; 48(4):204-7. PubMed ID: 12730725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dok-7 mutations underlie a neuromuscular junction synaptopathy.
    Beeson D; Higuchi O; Palace J; Cossins J; Spearman H; Maxwell S; Newsom-Davis J; Burke G; Fawcett P; Motomura M; Müller JS; Lochmüller H; Slater C; Vincent A; Yamanashi Y
    Science; 2006 Sep; 313(5795):1975-8. PubMed ID: 16917026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.
    Gomez CM; Maselli RA; Vohra BP; Navedo M; Stiles JR; Charnet P; Schott K; Rojas L; Keesey J; Verity A; Wollmann RW; Lasalde-Dominicci J
    Ann Neurol; 2002 Jan; 51(1):102-12. PubMed ID: 11782989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome.
    Liao X; Wang Y; Lai X; Wang S
    Biomol Biomed; 2023 Sep; 23(5):772-784. PubMed ID: 36815443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel beta subunit mutation causes a slow-channel syndrome by enhancing activation and decreasing the rate of agonist dissociation.
    Navedo MF; Lasalde-Dominicci JA; Báez-Pagán CA; Díaz-Pérez L; Rojas LV; Maselli RA; Staub J; Schott K; Zayas R; Gomez CM
    Mol Cell Neurosci; 2006; 32(1-2):82-90. PubMed ID: 16624571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes.
    Richard P; Gaudon K; Andreux F; Yasaki E; Prioleau C; Bauché S; Barois A; Ioos C; Mayer M; Routon MC; Mokhtari M; Leroy JP; Fournier E; Hainque B; Koenig J; Fardeau M; Eymard B; Hantaï D
    J Med Genet; 2003 Jun; 40(6):e81. PubMed ID: 12807980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.